Stopeck AT - Search Results

1

Transfection of primary tumor cells and tumor cell lines with plasmid DNA/lipid complexes.

Stopeck AT, Hersh EM, Brailey JL, Clark PR, Norman J, Parker SE. Stopeck AT, et al. Cancer Gene Ther. 1998 Mar-Apr;5(2):119-26. Cancer Gene Ther. 1998. PMID: 9570303

2

Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.

Parker SE, Khatibi S, Margalith M, Anderson D, Yankauckas M, Gromkowski SH, Latimer T, Lew D, Marquet M, Manthorpe M, Hobart P, Hersh E, Stopeck AT, Norman J. Parker SE, et al. Among authors: stopeck at. Cancer Gene Ther. 1996 May-Jun;3(3):175-85. Cancer Gene Ther. 1996. PMID: 8725882

3

Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells.

Clark PR, Stopeck AT, Brailey JL, Wang Q, McArthur J, Finer MH, Hersh EM. Clark PR, et al. Among authors: stopeck at. Cancer Gene Ther. 1999 Sep-Oct;6(5):437-46. doi: 10.1038/sj.cgt.7700074. Cancer Gene Ther. 1999. PMID: 10505854

4

Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA.

Clark PR, Stopeck AT, Ferrari M, Parker SE, Hersh EM. Clark PR, et al. Among authors: stopeck at. Cancer Gene Ther. 2000 Jun;7(6):853-60. doi: 10.1038/sj.cgt.7700184. Cancer Gene Ther. 2000. PMID: 10880015

5

Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft.

Clark PR, Stopeck AT, Parker SE, Hersh EM. Clark PR, et al. Among authors: stopeck at. Cell Immunol. 2000 Sep 15;204(2):96-104. doi: 10.1006/cimm.2000.1699. Cell Immunol. 2000. PMID: 11069717

6

Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC.

Panelli MC, Wang E, Shen S, Schluter SF, Bernstein RM, Hersh EM, Stopeck A, Gangavalli R, Barber J, Jolly D, Akporiaye ET. Panelli MC, et al. Cancer Immunol Immunother. 1996 Feb;42(2):99-107. doi: 10.1007/s002620050258. Cancer Immunol Immunother. 1996. PMID: 8620527 Free PMC article.

7

Phase I study of immunotherapy of malignant melanoma by direct gene transfer.

Hersh EM, Akporiaye E, Harris D, Stopeck AT, Unger EC, Warneke JA, Kradjian SA. Hersh EM, et al. Among authors: stopeck at. Hum Gene Ther. 1994 Nov;5(11):1371-84. doi: 10.1089/hum.1994.5.11-1371. Hum Gene Ther. 1994. PMID: 7893808 Clinical Trial. No abstract available.

8

Recent advances in the treatment of malignant melanoma with gene therapy.

Hersh EM, Stopeck AT. Hersh EM, et al. Among authors: stopeck at. Mol Med. 1997 Oct;3(10):636-51. Mol Med. 1997. PMID: 9392001 Free PMC article. Review. No abstract available.

9

Advances in the biological therapy and gene therapy of malignant disease.

Hersh EM, Stopeck AT. Hersh EM, et al. Among authors: stopeck at. Clin Cancer Res. 1997 Dec;3(12 Pt 2):2623-9. Clin Cancer Res. 1997. PMID: 10068264 Review.

10

Construction of new amplifier expression vectors for high levels of IL-2 gene expression.

Tsang TC, Brailey JL, Vasanwala FH, Wu RS, Liu F, Clark PR, Meade-Tollin L, Luznick L, Stopeck AT, Akporiaye ET, Harris DT. Tsang TC, et al. Among authors: stopeck at. Int J Mol Med. 2000 Mar;5(3):295-300. Int J Mol Med. 2000. PMID: 10677573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters